Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.

GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according ...

Theratechnologies entered a definitive agreement to be acquired by Future Pak. Find out why do not expect to see THTX stock ...

The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 months ...

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

Orfoglipron was associated with improved glycemic control and weight reduction among patients with early-stage type 2 diabetes.

The proceedings follow a PIL seeking a ban on sale of weight loss drugs that are still undergoing clinical trials ...